Angiodynamics (ANGO) Non-Current Debt (2011 - 2023)
Angiodynamics' (ANGO) quarterly Non-Current Debt came in at $49.8 million in Q2 2023, up 99.27% YoY from $25.0 million in Q2 2022, and little changed on a QoQ basis from $49.8 million in Q1 2023.
Angiodynamics (ANGO) Non-Current Debt (2011 - 2023) Analysis & Trends
Angiodynamics (ANGO) has 13 years of Non-Current Debt data on file, last reported at $49.8 million in Q2 2023.
- Quarterly Non-Current Debt rose 99.27% year-over-year to $49.8 million in Q2 2023, while the trailing twelve-month figure through May 2023 was $49.8 million (up 99.27% YoY) and the FY2023 annual result came in at $49.8 million, up 99.27% from the prior year.
- Non-Current Debt steadied at $49.8 million in Q2 2023, from $49.8 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $133.1 million in Q1 2019 to a low of $14.3 million in Q1 2020.
- A 5-year average of $46.3 million and a median of $40.0 million in 2020 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2020 — Non-Current Debt slumped 89.22% — and 2021, when it soared 109.19%.
- Tracing ANGO's Non-Current Debt over 5 years: stood at $124.4 million in 2019, then tumbled by 67.85% to $40.0 million in 2020, then plunged by 37.5% to $25.0 million in 2021, then soared by 99.18% to $49.8 million in 2022, then climbed by 0.04% to $49.8 million in 2023.
- The last three Non-Current Debt figures came in at $49.8 million (Q2 2023), $49.8 million (Q1 2023), and $49.8 million (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.68 Bn | 129.47 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.46 Bn | 51.59 Bn | 2.32 Bn | 13.51 Bn |
| 3 | Alcon | 35.84 Bn | 34.49 Bn | 1.68 Bn | 4.15 Bn |
| 4 | Resmed | 33.87 Bn | 32.40 Bn | 861.22 Mn | 399.42 Mn |
| 5 | Medline | 28.95 Bn | 26.27 Bn | 2.22 Bn | 12.55 Bn |
| 6 | West Pharmaceutical Services | 25.14 Bn | 24.71 Bn | 329.20 Mn | 202.90 Mn |
| 7 | Solventum | 15.35 Bn | 14.95 Bn | 1.29 Bn | 4.57 Bn |
| 8 | Cooper Companies | 14.90 Bn | 14.77 Bn | 735.40 Mn | 1.86 Bn |
| 9 | Baxter International | 13.66 Bn | 11.51 Bn | 1.03 Bn | 8.62 Bn |
| 10 | Angiodynamics | 650.30 Mn | 596.43 Mn | 46.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2023 | 49.82 Mn |
| Feb 28, 2023 | 49.81 Mn |
| Nov 30, 2022 | 49.80 Mn |
| Aug 31, 2022 | 49.80 Mn |
| May 31, 2022 | 25.00 Mn |
| Feb 28, 2022 | 25.00 Mn |
| Nov 30, 2021 | 25.00 Mn |
| Aug 31, 2021 | 25.00 Mn |
| May 31, 2021 | 20.00 Mn |
| Feb 28, 2021 | 30.00 Mn |
| Nov 30, 2020 | 40.00 Mn |
| Aug 31, 2020 | 40.00 Mn |
| May 31, 2020 | 40.00 Mn |
| Feb 29, 2020 | 14.34 Mn |
| May 31, 2019 | 124.41 Mn |
| Feb 28, 2019 | 133.09 Mn |
| Nov 30, 2018 | 144.27 Mn |
| Aug 31, 2018 | 85.44 Mn |
| May 31, 2018 | 86.62 Mn |
| Feb 28, 2018 | 92.80 Mn |